$1.16
+0.03 (+2.65%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,340.5% upside
Low Target
$12.81
Average Target
$16.71
High Target
$20.08
Current Price
$1.16
Current
$1.16
$1.16
Target
$16.71
$16.71
$12.81
$16.71 avg
$20.08
Scenario Analysis
Bear Case
$12.81
1,004.3%
Low target
Base Case
$16.71
+1,340.5%
Avg target
Bull Case
$20.08
+1,631.0%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$2.98
-61.1% from high
52-Week Low
$0.99
+17.2% from low
Target vs 52W High
$16.71
+460.7% vs high
Next Earnings Report
Nov 10, 2026
2d
until earnings
EPS Est: $-0.02
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals